Point of Care Fertility Testing Market 2024 To See Huge Growth by 2030 | Cognate Life Sciences

The Latest Research Report on Point of Care Fertility Testing Market 2024 covering the micro level of analysis by competitors and key business segments. The Global Point of Care Fertility Testing explores an inclusive study on various segments like growth drivers, opportunities, market size, shares, development, innovation, sales, and overall growth of major key players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing.

Get a sample PDF of the report in your inbox within 24 hours: https://www.cognatelifesciences.com/sample-request/2063/

Major Major Players are:

Alere Inc., Quidel Corporation, Prestige Brands Holdings, Inc., Chuch & Dwight Co., Inc., bioMérieux SA, Geratherm Medical AG, Abbott Laboratories, Procter & Gamble Co., DCC Plc., Swiss Precision Diagnostics GmbH

The Global Point of Care Fertility Testing Market is estimated to have reached a valuation of USD 1.4 billion in 2022 and is anticipated to attain a value of USD 1.98 billion by 2030, showcasing a growth rate of 4.4% during the forecast period of 2023-2030.

Point of Care Fertility

Point of care fertility testing refers to a type of medical examination conducted at or near the patient's treatment location, which could be at home, in a pharmacy, or a clinic. Individuals can monitor their reproductive health and strategically plan pregnancies through the utilization of point-of-care fertility testing. Various products, such as ovulation prediction kits, fertility monitors, sperm analyzers, and pregnancy tests, are employed for point-of-care fertility testing.

Global Point of Care Fertility Testing Market Drivers:

The declining fertility rates among both men and women serve as a significant driver for the demand for point-of-care fertility testing products:

Fertility rate, representing the average number of children a woman has throughout her lifetime, is influenced by a multitude of factors, encompassing biological, physiological, social, economic, and environmental elements. Factors like smoking, alcohol consumption, drug usage, obesity, stress, and chronic illnesses can contribute to reduced fertility in both genders. For example, smoking has been linked to diminished quantity and quality of male sperm, as well as an increased risk of infertility and miscarriage in females. Obesity can lead to decreased sperm quality and erectile dysfunction in males, and hormonal abnormalities and ovulation issues in females. Age also plays a role, with fertility decreasing notably after 35 for women and 40 for men. The use of contraception, sterilization, or abortion can influence family planning decisions, and accessibility and effectiveness of these methods vary across different regions. Some individuals may opt for fewer or no children due to social or personal considerations.

The increasing prevalence of conditions like polycystic ovarian syndrome (PCOS) contributes to the demand for point-of-care fertility testing tools:

PCOS is characterized by the abnormal production of androgens, male sex hormones, by the ovaries in women. This condition can impact ovulation and fertility, accompanied by symptoms such as irregular periods, excessive body hair, acne, weight gain, and insulin resistance. Women with PCOS may face challenges in becoming pregnant due to irregular or absent ovulation. Point-of-care fertility testing tools like ovulation prediction kits and fertility monitors empower women with PCOS to monitor their ovulation patterns and identify fertile days. Additionally, women with PCOS can use pregnancy tests and home blood pressure monitors for confirming pregnancy and monitoring health during pregnancy, reducing the risks of complications such as preterm delivery, gestational diabetes, and preeclampsia.

Global Point of Care Fertility Testing Market Challenges:

Factors impeding the demand for fertility test kits may decelerate the market's growth:

The fertility and pregnancy test sector witness intense competition, with numerous established national and regional firms striving for market supremacy. This scenario can lead to challenges such as confusion and trust issues, prompting consumers to opt for alternative laboratory test brands. Additionally, healthcare professionals often prefer laboratory diagnoses over home testing kits. Unreliable outcomes, including false positives and negatives, discourage some consumers from choosing home pregnancy tests, resulting in reduced product sales and serving as a substantial market constraint for quick test kits in the fertility and pregnancy product category. Limited awareness of fertility and pregnancy fast test kits and financial constraints preventing product purchase also contribute to somewhat restraining the global market's expansion. The resistance to adopting these products in potentially lucrative markets suggests obstacles to market enlargement.

COVID-19 Impact on Global Point of Care Fertility Testing Market:

COVID-19 has left a lasting impact on various sectors, including healthcare. Supply shortages and delayed laboratory visits have hindered daily diagnostic test procedures. The market for fertility and pregnancy quick test kits was expected to witness significant expansion as the demand for self-test kits, including midstream kits, and point-of-care kits surged. The preference to stay at home during the pandemic, rather than visiting hospitals, fueled this trend. For instance, Apollo Pharmacy reported over a 50% increase in sales in India, which was linked to the use of pregnancy quick test kits during the COVID-19 period. The market is anticipated to continue expanding, with fertility and pregnancy fast test kits gaining more reliance from consumers over the projection period.

Get a Impressive Discount on corporate email id @ https://www.cognatelifesciences.com/discount-request/2063/

Market Segmentation are:

by Type (Human chorionic, Gonadotropin (HCG) urine test, FSH urine test, Human chorionic Gonadotropin (HCG) blood test, Luteinizing hormone (LH) urine test); By Fertility Tests (Line-Indicator, Digital); By Distribution Channel (Hypermarkets & supermarkets, Gynecology & Fertility clinics, Pharmacy, Online sales); By End-User (Hospitals & Clinics, Research Institutes, Diagnostic Laboratories); and Region - Size, Share, Growth Analysis | Forecast (2024 2030)

Point of Care Fertility Testing insights, overview and deep study of factors are considered to have greater influence over future course of the industry such as market size, market share, different dynamics of the industry, Point of Care Fertility Testing market companies, regional analysis of the domestic markets, value chain analysis, consumption, demand, key application areas and more.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

How will this report benefit potential stakeholders?
-Comprehensive assessment of all opportunities and risks in the Point of Care Fertility Testing market.
-The detailed study of business strategies for the growth of the Point of Care Fertility Testing market-leading players.
-Conclusive study about the growth plot of the Point of Care Fertility Testing market for forthcoming years.
-In-depth understanding of Point of Care Fertility Testing market-particular drivers, constraints, and major micro markets.
-Favorable impression inside vital technological and market latest trends striking the Point of Care Fertility Testing market.

Any Questions? Feel Free To Enquire Here. Well put you on the Right Path @ https://www.cognatelifesciences.com/enquiry-request/2063/

What Point of Care Fertility Testing Market report offers:
1.Point of Care Fertility Testing Market share assessments for the regional and country-level segments
2.Market share analysis of the top industry players
3.Point of Care Fertility Testing Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
4.Strategic recommendations in key business segments based on the market estimations
5.Competitive landscape covering following points: Company Overview, Product Portfolio, Financial Performance, Recent Highlights, Strategies

COVID-19 has had a major impact on the world economy in addition to that on the public health. This particular pandemic had caused severe economic destruction and not a single country has been left unaffected. The virus has forced businesses around the globe to change the way they operate. This report gives an analysis of the COVID-19 aftermath on Point of Care Fertility Testing market.

Competitive Rivalry:

The report highlights vital details based on the leading players in the global Industrial Point of Care Fertility Testing market. It features their details such as product/business portfolio, market share, financial status, regional share, segment revenue, SWOT analysis, manufacturing base, capacities, production volume, major vendors, raw material sourcing strategies, organizational structure. Their latest corporate deals, joint ventures, mergers and acquisitions, product launches, and other brand promotions are other facts about the market players included in the report.

We also offer customization on reports based on specific client requirement:

1- country-level analysis for any 5 countries of your choice.
2- Competitive analysis of any market players.
3- 40 analyst hours to cover any other data points

Purchase this report now @ https://www.cognatelifesciences.com/buy-now/?id=2063&license_type=su

Finally, Point of Care Fertility Testing Market is a valuable source of guidance for individuals and companies in decision framework.

Contact Us:
Robin McKay
Client Partner Relations
USA/Canada(Toll Free): 1800-601-6071
Mail: sales@cognatelifesciences.com
Web: www.cognatelifesciences.com

About us :

Cognate Lifesciences is a specialized hub for all market research reports related to Lifesciences Market. Some of the sub domains covered by our team are Pharmaceuticals, Medical Devices and Supplies, Healthcare, Diagnostics, Biotech, Therapeutics, Healthcare IT etc. We offer syndicated/customized market research studies along with advisory and consulting services.

This release was published on openPR.